Correlation between systemic oxidative stress and intraocular pressure level

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Tanito, Masaki ^a,b   Kaidzu, Sachiko ^b   Takai, Yasuyuki ^b   Ohira, Akihiro ^b  

^a MATSUE RED CROSS HOSPITAL   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE; FREE RADICAL;

AGED; ANALYSIS OF VARIANCE; ANTIOXIDANT ASSAY; ARTICLE; BIOLOGICAL ANTIOXIDANT POTENTIAL; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FERRIC REDUCING ACTIVITY; HUMAN; INTRAOCULAR PRESSURE; JAPANESE (PEOPLE); LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; OXIDATIVE STRESS; PATHOGENESIS; POST HOC ANALYSIS; PSEUDOEXFOLIATION; ADULT; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EXFOLIATION SYNDROME; FEMALE; FREE RADICALS; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 84941350010     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133582     Document Type: Article

References (57)

1. Foster A, Resnikoff S. The impact of Vision 2020 on global blindness. Eye (Lond). 2005;19:1133-1135.
2. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720. PMID: 15158634
3. Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, Kitazawa Y. Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology. 2006;113:1354-1362. PMID: 16877074
4. Alvarado JA, Murphy CG. Outflow obstruction in pigmentary and primary open angle glaucoma. Arch Ophthalmol. 1992;110:1769-1778. PMID: 1463421
5. Lutjen-Drecoll E, Shimizu T, Rohrbach M, Rohen JW. Quantitative analysis of 'plaque material' in the inner- and outer wall of Schlemm's canal in normal- and glaucomatous eyes. Exp Eye Res. 1986;42:443-455. PMID: 3720863
6. Izzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma. Mutat Res. 2006;612:105-114. PMID: 16413223
7. Sacca SC, Izzotti A, Rossi P, Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp Eye Res. 2007;84:389-399. PMID: 17196589
8. Luna C, Li G, Liton PB, Qiu J, Epstein DL, Challa P, et al. Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem Toxicol. 2009;47:198-204. doi: 10.1016/j.fct.2008.10.029 PMID: 19027816
9. Izzotti A, Longobardi M, Cartiglia C, Sacca SC. Mitochondrial damage in the trabecular meshwork occurs only in primary open-angle glaucoma and in pseudoexfoliative glaucoma. PLoS One. 2011;6:e14567. doi: 10.1371/journal.pone.0014567 PMID: 21283745
10. Takai Y, Tanito M, Ohira A. Multiplex cytokine analysis of aqueous humor in eyes with primary openangle glaucoma, exfoliation glaucoma, and cataract. Invest Ophthalmol Vis Sci. 2012;53:241-247. doi: 10.1167/iovs.11-8434 PMID: 22159018
11. Yang J, Tezel G, Patil RV, Romano C, Wax MB. Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest Ophthalmol Vis Sci. 2001;42:1273-1276. PMID: 11328739
12. Wax MB, Tezel G, Saito I, Gupta RS, Harley JB, Li Z, et al. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol. 1998;125:145-157. PMID: 9467439
13. Tezel G, Seigel GM, Wax MB. Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci. 1998;39:2277-2287. PMID: 9804136
14. Yildirim O, Ates NA, Ercan B, Muslu N, Unlu A, Tamer L, et al. Role of oxidative stress enzymes in open-angle glaucoma. Eye (Lond). 2005;19:580-583.
15. Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2005;46:877-883. PMID: 15728543
16. Yagci R, Ersoz I, Erdurmus M, Gurel A, Duman S. Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome. Eye (Lond). 2008;22:128-131.
17. Koliakos GG, Befani CD, Mikropoulos D, Ziakas NG, Konstas AG. Prooxidant-antioxidant balance, peroxide and catalase activity in the aqueous humourand serum of patients with exfoliation syndrome or exfoliative glaucoma. Graefes Arch Clin Exp Ophthalmol. 2008;246:1477-1483. doi: 10.1007/s00417-008-0871-y PMID: 18607617
18. Cumurcu T, Gunduz A, Ozyurt H, Nurcin H, Atis O, Egri M. Increased oxidative stress in patients with pseudoexfoliation syndrome. Ophthalmic Res. 2010;43:169-172. doi: 10.1159/000272019 PMID: 20068368
19. Yuki K, Murat D, Kimura I, Tsubota K. Increased serum total antioxidant status and decreased urinary 8-hydroxy-2'-deoxyguanosine levels in patients with normal-tension glaucoma. Acta Ophthalmol. 2010;88:e259-264. doi: 10.1111/j.1755-3768.2010.01997.x PMID: 20977690
20. Engin KN, Yemisci B, Yigit U, Agachan A, Coskun C. Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients. Mol Vis. 2010;16:1260-1271. PMID: 20664701
21. Majsterek I, Malinowska K, Stanczyk M, Kowalski M, Blaszczyk J, Kurowska AK, et al. Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma. Exp Mol Pathol. 2011;90:231-237. doi: 10.1016/j.yexmp. 2011.01.001 PMID: 21241689
22. Sorkhabi R, Ghorbanihaghjo A, Javadzadeh A, Rashtchizadeh N, Moharrery M. Oxidative DNA damage and total antioxidant status in glaucoma patients. Mol Vis. 2011;17:41-46. PMID: 21245957
23. Erdurmus M, Yagci R, Atis O, Karadag R, Akbas A, Hepsen IF. Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr Eye Res. 2011;36:713-718. doi: 10.3109/02713683.2011.584370 PMID: 21780920
24. Nucci C, Di Pierro D, Varesi C, Ciuffoletti E, Russo R, Gentile R, et al. Increased malondialdehyde concentration and reduced total antioxidant capacity in aqueous humor and blood samples from patients with glaucoma. Mol Vis. 2013;19:1841-1846. PMID: 23946639
25. Yuki K, Tsubota K. Increased Urinary 8-Hydroxy-2'-deoxyguanosine (8-OHdG)/Creatinine Level is Associated with the Progression of Normal-Tension Glaucoma. Curr Eye Res. 2013;38:983-988. doi: 10.3109/02713683.2013.800889 PMID: 23767426
26. Demirdogen BC, Ceylan OM, Isikoglu S, Mumcuoglu T, Erel O. Evaluation of oxidative stress and paraoxonase phenotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Clin Lab. 2014;60:79-86. PMID: 24600979
27. Lopez-Riquelme N, Villalba C, Tormo C, Belmonte A, Fernandez C, Torralba G, et al. Endothelin-1 levels and biomarkers of oxidative stress in glaucoma patients. Int Ophthalmol. 2014;35:527-532. doi: 10.1007/s10792-014-9979-8 PMID: 25079761
28. Tanito M, Kaidzu S, Takai Y, Ohira A. Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndrome. PLoSOne. 2012;7:e49680. doi: 10.1371/journal.pone.0049680 PMID: 23189153
29. Izzotti A, Sacca SC, Cartiglia C, De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med. 2003;114:638-646. PMID: 12798451
30. Sacca SC, Pascotto A, Camicione P, Capris P, Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol. 2005;123:458-463. PMID: 15824217
31. Vassalle C, Pratali L, Boni C, Mercuri A, Ndreu R. An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease. Clin Biochem. 2008;41:1162-1167. doi: 10.1016/j.clinbiochem.2008.07.005 PMID: 18692492
32. Nakayama K, Terawaki H, Nakayama M, Iwabuchi M, Sato T, Ito S. Reduction of serum antioxidative capacity during hemodialysis. Clin Exp Nephrol. 2007;11:218-224. PMID: 17891349
33. Shimano M, Shibata R, Inden Y, Yoshida N, Uchikawa T, Tsuji Y, et al. Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation. Heart Rhythm. 2009;6:935-940. doi: 10.1016/j.hrthm.2009.03.012 PMID: 19560081
34. Cornelli U, Terranova R, Luca S, Cornelli M, Alberti A. Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr. 2001;131:3208-3211. PMID: 11739867
35. Martinovic J, Dopsaj V, Dopsaj MJ, Kotur-Stevuljevic J, Vujovic A, Stefanovic A, et al. Long-term effects of oxidative stress in volleyball players. Int J Sports Med. 2009;30:851-856. doi: 10.1055/s-0029-1238289 PMID: 20013555
36. Kotani K, Koibuchi H, Miyamoto M, Yamada T, Taniguchi N. Relationship between reactive oxygen metabolites and carotid intima-media thickness in subjects with hypercholesterolemia. Med Princ Pract. 2010;19:496-498. doi: 10.1159/000320312 PMID: 20881421
37. Carratelli M, Porcaro L, Ruscica M, De Simone E, Bertelli AA, Corsi MM. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome. Int J Clin Pharmacol Res. 2001;21:79-84. PMID: 11824651
38. Pasquini A, Luchetti E, Marchetti V, Cardini G, Iorio EL. Analytical performances of d-ROMs test and BAP test in canine plasma. Definition of the normal range in healthy Labrador dogs. Vet ResCommun. 2008;32:137-143. PMID: 17846911
39. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70-77. PMID: 13650640
40. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968;25:192-205. PMID: 4973948
41. Himori N, Yamamoto K, Maruyama K, Ryu M, Taguchi K, Yamamoto M, et al. Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death. J Neurochem. 2013;127:669-680. doi: 10.1111/jnc. 12325 PMID: 23721546
42. Yokoyama Y, Maruyama K, Yamamoto K, Omodaka K, Yasuda M, Himori N, et al. The role of calpain in an in vivo model of oxidative stress-induced retinal ganglion cell damage. Biochem Biophys Res Commun. 2014;451:510-515. doi: 10.1016/j.bbrc.2014.08.009 PMID: 25111816
43. Inomata Y, Nakamura H, Tanito M, Teratani A, Kawaji T, Kondo N, et al. Thioredoxin inhibits NMDA-induced neurotoxicity in the rat retina. J Neurochem. 2006;98:372-385. PMID: 16805832
44. Munemasa Y, Ahn JH, Kwong JM, Caprioli J, Piri N. Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma. GeneTher. 2009;16:17-25. doi: 10. 1038/gt.2008.126 PMID: 18701913
45. Kitaoka Y, Munemasa Y, Hayashi Y, Kuribayashi J, Koseki N, Kojima K, et al. Axonal protection by 17beta-estradiol through thioredoxin-1 in tumor necrosis factor-induced optic neuropathy. Endocrinology. 2011;152:2775-2785. doi: 10.1210/en. 2011-0046 PMID: 21586560
46. Zhou L, Li Y, Yue BY. Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J Cell Physiol. 1999;180:182-189. PMID: 10395288
47. Kahn MG, Giblin FJ, Epstein DL. Glutathione in calf trabecular meshwork and its relation to aqueous humor outflow facility. Invest Ophthalmol Vis Sci. 1983;24:1283-1287. PMID: 6885312
48. Beyazyildiz E, Cankaya AB, Beyazyildiz O, Ergan E, Celik HT, Yilmazbas P, et al. Disturbed oxidant/antioxidant balance in aqueous humour of patients with exfoliation syndrome. Jpn J Ophthalmol. 2014;58:353-358. doi: 10.1007/s 10384-014-0325-5 PMID: 24859894
49. Li L, Duker JS, Yoshida Y, Niki E, Rasmussen H, Russell RM, et al. Oxidative stress and antioxidant status in older adults with early cataract. Eye (Lond). 2009;23:1464-1468.
50. Virgolici B, Stoian I, Muscurel C, Maracine M, Moraru C, Dinu V. Plasma redox status and premature onset of senile cataract. Rom J Intern Med. 2007, 45:59-65. PMID: 17966444
51. Nakamura H, De Rosa SC, Yodoi J, Holmgren A, Ghezzi P, Herzenberg LA, et al. Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci USA. 2001;98:2688-2693. PMID: 11226300
52. Michelet F, Gueguen R, Leroy P, Wellman M, Nicolas A, Siest G. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin Chem. 1995;41:1509-1517. PMID: 7586526
53. Lamoke F, Ripandelli G, Webster S, Montemari A, Maraschi A, Martin P, et al. Loss of thioredoxin function in retinas of mice overexpressing amyloid beta. Free Radic Biol Med. 2012;53:577-588. doi: 10. 1016/j.freeradbiomed.2012.04.010 PMID: 22564527
54. Fatma N, Kubo E, Toris CB, Stamer WD, Camras CB, Singh DP. PRDX6 attenuates oxidative stress and TGFbeta-induced abnormalities of human trabecular meshwork cells. Free Radic Res. 2009;43:783-795. doi: 10.1080/10715760903062887 PMID: 19572226
55. Miyamoto N, Izumi H, Miyamoto R, Kondo H, Tawara A, Sasaguri Y, et al. Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway. Invest Ophthalmol Vis Sci. 2011;52:1055-1063. doi: 10.1167/iovs.10-5777 PMID: 21051700
56. Tehrani S. Gender difference in the pathophysiology and treatment of glaucoma. Curr Eye Res. 2015;40:191-200. doi: 10.3109/02713683.2014.968935 PMID: 25285808
57. He Z, Vingrys AJ, Armitage JA, Bui BV. The role of blood pressure in glaucoma. Clin Exp Optom. 2011;94:133-149. doi: 10.1111/j.1444-0938.2010.00564.x PMID: 21255075